Precigen, Inc
Clinical trials sponsored by Precigen, Inc, explained in plain language.
-
New combo aims to revive immune attack on hard-to-treat cervical cancer
Disease control Recruiting nowThis study tests a new drug, PRGN-2009, combined with pembrolizumab in 24 adults whose recurrent or metastatic cervical cancer no longer responds to pembrolizumab alone. The goal is to see if the combination can shrink tumors or stop them from growing. Participants must have HPV-…
Phase: PHASE2 • Sponsor: Precigen, Inc • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Gene therapy retreatment shows promise for rare throat tumor condition
Disease control Recruiting nowThis study tests a gene therapy called Zopapogene imadenovec (Zopa) in adults with recurrent respiratory papillomatosis (RRP), a rare condition causing non-cancerous throat tumors that often come back after surgery. The study has two groups: one checks how the virus used in the t…
Phase: PHASE4 • Sponsor: Precigen, Inc • Aim: Disease control
Last updated May 14, 2026 12:06 UTC